Vanguard Asset Management’s ANI Pharmaceuticals ANIP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$897K Sell
12,346
-2,115
-15% -$163K ﹤0.01% 1908
2026
Q2
$1.2M Buy
14,461
+2,723
+23% +$218K ﹤0.01% 1800
2026
Q1
$903K Buy
+11,738
New +$916K ﹤0.01% 1839

Other funds holding ANIP

Vanguard Asset Management's ANIP Position: Q3 2026 in Review

Vanguard Asset Management reduced its ANI Pharmaceuticals (ANIP) stake by 15% in Q3 2026, selling an estimated $163K and leaving 12,346 shares worth $897K. The position accounts for ﹤0.01% of the portfolio, ranked #1908.

Vanguard Asset Management first reported a position in ANIP in Q1 2026 and has held it in 3 quarters since. The position peaked at $1.2M in Q2 2026. 291 funds tracked by Wall St. Rank hold ANIP as of Q3 2026.

  • Vanguard Asset Management held 12,346 shares of ANI Pharmaceuticals worth $897K as of Q3 2026.
  • Vanguard Asset Management sold 2,115 ANI Pharmaceuticals shares in Q3 2026, an estimated $163K.
  • ANI Pharmaceuticals made up ﹤0.01% of Vanguard Asset Management's portfolio in Q3 2026, its #1908 holding.
  • Vanguard Asset Management first reported a position in ANI Pharmaceuticals in Q1 2026 and has held it in 3 quarters since.
  • Vanguard Asset Management's ANI Pharmaceuticals position peaked at $1.2M in Q2 2026.
  • 291 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q3 2026.

Based on Vanguard Asset Management's 13F filing for Q3 2026, filed 13 Nov 2026.